ANALYSIS OF GLOMERULAR TRANSCRIPTOMES FROM NEPHROTIC PATIENTS SUGGEST APOL1 RISK VARIANTS IMPACT PARIETAL EPITHELIAL CELLS

Agustin Gonzalez-Vicente,Dana C. Crawford,William S. Bush,Zhenzhen Wu,Leslie A. Bruggeman,Viji Nair,Felix Eichinger,Oliver Wessely,Matthias Kretzler,John F. O'Toole,John R. Sedor,Kidney Precision Medicine Project,Nephrotic Syndrome Study Network

DOI: https://doi.org/10.1101/2024.11.05.24316766

2024-11-05

Abstract:The disproportionate risk for idiopathic proteinuric podocytopathies in Black people is explained, in part, by the presence of two risk alleles (G1 or G2) in the APOL1 gene. The pathogenic mechanisms responsible for this genetic association remain incompletely understood. We analyzed glomerular RNASeq transcriptomes from patients with idiopathic nephrotic syndrome of which 72 had inferred African ancestry (AA) and 152 did not (noAA). Using gene coexpression networks we found a significant association between APOL1 risk allele number and the coexpression metamodule 2 (MM2), even after adjustment for eGFR and proteinuria at biopsy. Unadjusted Kaplan-Meier curves showed that unlike noAA, AA with the highest tertile of MM2 gene activation scores were less likely to achieve complete remission (p≤0.014). Characteristic direction (ChDir) identified a signature of 1481 genes, which separated patients with APOL1 risk alleles from those homozygous for reference APOL1. Only in AA, the tertile with the highest activation scores of these 1481 genes was less likely to achieve complete remission (p≤0.022) and showed a trend to faster progression to the composite event of kidney failure or loss of 40% eGFR (p≤0.099). The MM2 and ChDir genes significantly overlapped and were both enriched for Epithelial Mesenchymal Transition and inflammation terms. Finally, MM2 significantly overlapped with a parietal epithelial cell (PEC)-identity gene signature but not with a podocyte identity signature. Podocytes expressing variant APOL1s may generate inflammatory signals that activate PECs by paracrine mechanisms contributing to APOL1 nephropathy.

Genetic and Genomic Medicine

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore how APOL1 risk variants affect the podocytes transcriptome in patients with nephrotic syndrome, and further investigate whether and how these genetic variants activate parietal epithelial cells (PECs) through paracrine mechanisms, thereby leading to the occurrence and development of kidney diseases. Specifically, the researchers analyzed the RNA - sequencing data of glomeruli from patients in the NEPTUNE (Nephrotic Syndrome Study Network) cohort, especially those patients with African Ancestry (AA) background and carrying APOL1 risk alleles. They hope to find gene expression characteristics related to APOL1 risk variants through these analyses, and how these characteristics are associated with the clinical outcomes of the disease.

The main findings of the paper include:
1. **APOL1 risk variants are associated with specific gene modules**: Through weighted gene co - expression network analysis (WGCNA), the researchers found several gene modules that are significantly associated with the number of APOL1 risk alleles, especially the MM2 module. The genes in these modules show higher expression levels in individuals with a higher number of APOL1 risk variants.
2. **Clinical prognosis is associated with gene module activation**: For individuals carrying APOL1 risk variants, a high activation score of the MM2 module is associated with a poorer clinical prognosis, such as a lower complete remission rate and a faster rate of renal function decline.
3. **The impact of APOL1 risk variants on PECs**: The study also found that APOL1 risk variants not only affect the podocytes transcriptome but also significantly change the gene expression pattern of PECs. This indicates that APOL1 may transmit signals from podocytes to PECs through an as - yet - undefined paracrine pathway, thereby promoting the activation of PECs and participating in the process of glomerular injury.

In summary, this study aims to reveal the molecular mechanisms of APOL1 risk variants in patients with nephrotic syndrome, especially the interaction between podocytes and PECs and its impact on disease progression. This research provides a new perspective for understanding the pathogenesis of APOL1 - related kidney diseases and may provide a theoretical basis for future treatment strategies.